Sleep apnoea, insulin resistance and diabetes: the first step is in the fat

Isaac Almendros, Francisco García-Río

Source: Eur Respir J , 49 (4) 1700179; DOI: 10.1183/13993003.00179-2017

Journal Issue: April

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Isaac Almendros, Francisco García-Río. Sleep apnoea, insulin resistance and diabetes: the first step is in the fat. Eur Respir J , 49 (4) 1700179; DOI: 10.1183/13993003.00179-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Insulin resistance and insulin sensitivity in patients with sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Sleep, sleep-disordered breathing and metabolic consequences Source: Eur Respir J 2009; 34: 243-260 Year: 2009
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003
Comparison of the association with sleep apnoea of obesity versus insulin resistance Source: Eur Respir J 2015; 46: 1829-1832 Year: 2015
Obstructive sleep apnoea is associated with decreased insulin sensitivity in females Source: Eur Respir J 2008; 31: 1054-1060 Year: 2008
Metabolic consequences in obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006
Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Diabetes and metabolic aspects of OSA Source: Eur Respir Mon 2010; 50: 189-215 Year: 2010
Case controlled study: sleep apnoea clinic patients have insulin resistance and dyslipidaemia Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
The influence of obstructive sleep apnoea and obesity on adiponectin, leptin, IGFBP-1 and HOMA-IR Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016
Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults? Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders Year: 2003
Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females Source: Eur Respir J 2014; 43: 145-155 Year: 2004
The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
Sleep apnoea and diabetes: a complex relationship Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities Year: 2016
Treatment effects of sleep apnoea: where are we now? Source: Eur Respir Rev 2007; 16: 146-168 Year: 2007